Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors.

Source:http://linkedlifedata.com/resource/pubmed/id/19680293

Download in:

View as

General Info

PMID
19680293